文献速递青光眼小儿眼科与斜弱视角膜与眼表疾病

新生儿起病的先天性葡萄膜外翻可能由一种独特的CYP1B1致病性变异引起

Neonatal-Onset Congenital Ectropion Uveae May Be Caused by a Distinct CYP1B1 Pathologic Variant.
PubMed 文献 · Am J Ophthalmol · 2022-01-24

这项前瞻性队列研究纳入13例新生儿起病先天性葡萄膜外翻(NO-CEU)患儿,全部在出生时发生青光眼且为严重双侧病变。12/13(92.3%)携带CYP1B1变异,其中9/12(83.3%)为c.1169G>A(p.Arg390His)纯合,表现为难治性青光眼并需多次手术;3例复合杂合变异者视觉预后较好。作者认为NO-CEU可能是特定CYP1B1基因型的表型标志。

要点

  • 13例NO-CEU患儿均在出生时发生青光眼,均为严重双侧病变。
  • 12/13(92.3%)携带CYP1B1变异,9/12(83.3%)为c.1169G>A(p.Arg390His)纯合且需多次手术。
  • 3例复合杂合CYP1B1变异者视觉预后较好。

核心结论

  • NO-CEU似乎是特定CYP1B1基因型的表型标志,本研究中其中之一为c.1169G>A(p.Arg390His)。
  • 表型识别有助于明确潜在的遗传变异。

研究设计与样本

  • 前瞻性队列研究,在三级医疗教学机构开展。
  • 纳入13例临床诊断为NO-CEU、完成青光眼手术后1年随访并接受临床外显子测序(CES)的儿童,CES采用选择性捕获并测序包括19个NO-CEU候选基因在内的蛋白编码区。
  • 对所有候选基因的变异采用同一标准评估致病性。

主要发现

  • 13例NO-CEU患者均在出生时发生青光眼,均为严重双侧病变。
  • 12/13(92.3%)患者携带CYP1B1变异;其中9/12(83.3%)为CYP1B1第3外显子c.1169G>A(p.Arg390His)纯合,并伴有5个常见纯合单核苷酸多态性 flanking 该致病变异。
  • 9例c.1169G>A(p.Arg390His)纯合患者为难以控制的青光眼,需要多次手术;6例患者存在持续性角膜混浊,需行光学虹膜切除术。
  • 3例患者为CYP1B1复合杂合变异,分别为c.1169G>A(p.Arg390His)与c.1103G>A(p.Arg368His)、c.1103G>A(p.Arg368His)与c.1403_1429dup(p.Arg468_Ser476dup)、c.1063C>T(p.Arg355Ter)与c.1325del(p.Pro442GlnfsTer15);这些患者视觉预后较好。

关键数值与推荐

  • 主要结局指标:结合先天性青光眼临床指征,在CES中发现的遗传变异。
  • 次要结局指标:基线与1年随访时的角膜透明度和眼压(IOP)、控制IOP所需的干预以及术后视力。
  • 遗传变异与结局进行关联分析。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report underlying genetic variants of recently described distinct phenotype of newborn glaucoma: neonatal-onset congenital ectropion uveae (NO-CEU). DESIGN: Prospective cohort study. METHODS: Setting: tertiary care teaching institute. SUBJECTS: Thirteen children with clinical diagnosis of NO-CEU who had completed 1-year follow-up after glaucoma surgery and had undergone clinical exome sequencing (CES) by selective capture and sequencing of the protein-coding regions of the genes including 19 candidate genes for NO-CEU were assessed. The same criteria were applied for evaluating pathogenicity of variants to all the candidate genes. OUTCOME MEASURES: primary-genetic variants found on CES keeping in view the clinical indication of congenital glaucoma; secondary-corneal clarity and intraocular pressure (IOP) at baseline and 1-year follow-up, interventions required to control IOP, and postoperative visual acuity. The genetic variants were correlated with the outcome. RESULTS: All 13 patients diagnosed with NO-CEU had onset of glaucoma at birth and severe bilateral disease. Twelve of 13 (92.3%) patients harbored CYP1B1 variants. Nine of these 12 patients (83.3%) were homozygous for [c.1169G>A(p.Arg390His)] in exon-3 of CYP1B, with 5 common homozygous single-nucleotide polymorphisms flanking the pathogenic variant. They had intractable glaucoma and required multiple surgeries. Six patients had persistent corneal opacities, necessitating optical iridectomies. Three patients were compound heterozygous for CYP1B1 variants, showing [c.1169G>A(p.Arg390His)] along with [c.1103G>A(p.Arg368His)], [c.1103G>A (p.Arg368His)] along with [c.1403_1429dup(p.Arg468_Ser476dup)], and [(c.1063C>T(p.Arg355Ter)] along with [c.1325del(p.Pro442GlnfsTer15)]. These patients had better visual outcomes. CONCLUSIONS: NO-CEU appears to be a phenotypic marker for specific CYP1B1 genotypes, one of which is [c.1169G>A(p.Arg390His)] in our study population. Phenotype recognition is helpful to characterize the underlying genetic variants.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kaushik S, Choudhary S, Kaur A, et al. Neonatal-Onset Congenital Ectropion Uveae May Be Caused by a Distinct CYP1B1 Pathologic Variant. Am J Ophthalmol. 2022. PMID: 35085548. doi:10.1016/j.ajo.2022.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。